Home › Blog › Weight Loss › How to Get Mounjaro UK

How to Get Mounjaro UK 2026: The Complete Step-by-Step Guide — NHS, Private and Online

Overview: How to Get Mounjaro in the UK

Mounjaro (tirzepatide) is the most effective weight loss treatment currently available in the UK, with average weight loss of 22.5% of starting body weight over 72 weeks. More than 2 million UK adults are now accessing it privately. But as a prescription-only medicine, it cannot be purchased over the counter — it requires a clinical assessment and a valid UK prescription.

There are three legitimate routes to getting Mounjaro in the UK in 2026: through the NHS (free but highly restricted), through a private GP, or through a GPhC-registered online pharmacy. For most people currently reading this guide, the online pharmacy route is the fastest, most accessible, and most cost-effective path — typically delivering your first pen within 24 hours of approval.

This guide explains every route in full, walks you through exactly what the process looks like at Slinic, and gives you the framework to choose a provider safely.

The 3 Routes to Getting Mounjaro in the UK

Route 1: Getting Mounjaro on the NHS

NICE TA1026 approved Mounjaro for NHS prescribing in 2025 — but the rollout is highly phased and the eligibility criteria are currently very restrictive. Here is the honest picture for 2026.

Current NHS eligibility (June 2026)

In the first phase of the NHS GP rollout (which began June 2025), Mounjaro is available to patients who:

• Have a BMI of 40 or above with at least four qualifying weight-related health conditions, or
• Have a BMI of 35 or above with specific high-risk comorbidity profiles including type 2 diabetes with poor control, established cardiovascular disease, and additional qualifying conditions

This means most patients currently accessing Mounjaro privately — those with BMI between 30 and 40, or with fewer qualifying conditions — do not meet NHS eligibility in 2026. The threshold will widen over the 12-year rollout programme, but this will be gradual. Broader NHS GP access is expected to expand from approximately mid-2026 onwards, but rollout speed varies significantly by Integrated Care Board area.

How NHS Mounjaro is accessed

NHS Wegovy (semaglutide) access

NHS Wegovy has been available through specialist tier 3 weight management services since 2024 under NICE TA875, for patients with BMI 35+ with qualifying conditions. Waiting times in most areas are 12–24 months. For patients who qualify for NHS Wegovy but are waiting, private access through Slinic — starting at £99.99/pen — may be a faster route to the same MHRA-licensed medication while you wait for NHS access.

Route 2: Getting Mounjaro Via a Private GP

A private GP can assess your eligibility and issue a Mounjaro prescription, which you then take to a pharmacy to dispense. This route suits patients who prefer face-to-face clinical assessment or who have complex medical histories that benefit from in-person review.

How it works

1. Book a private GP appointment — typical consultation fee £80–£200 depending on provider and location
2. GP assesses eligibility including BMI, weight verification, medical history, and contraindications
3. If eligible, GP issues a private prescription
4. Take prescription to a registered pharmacy to dispense — or use a pharmacy that dispenses against private prescriptions

Considerations

• The consultation fee adds to your total cost — typically £80–£200 on top of the pen price
• Monthly review appointments add further cost over time
• Some GPs can issue ongoing prescriptions remotely after the initial face-to-face assessment
• This route tends to work best for patients with complex medical histories or multiple medications requiring careful review

Route 3: Online GPhC-Registered Pharmacy (Fastest Route)

For most patients in the UK, an online GPhC-registered pharmacy is the fastest, most accessible, and most cost-effective route to Mounjaro. This is the route used by the majority of the 2 million+ UK adults currently accessing weight loss injections privately. Here is how it works and what to look for.

How online pharmacy prescribing works

Under UK pharmacy law and GPhC regulations, registered online pharmacies can issue private prescriptions following an online clinical assessment — provided that assessment is reviewed by a registered UK prescriber (doctor, nurse prescriber, or pharmacist prescriber) and meets the standards required for Mounjaro prescribing. This includes independent verification of weight, height, and BMI following updated GPhC guidance issued in February 2025.

The process is fast — in most cases, from completing your eligibility assessment to having your first Mounjaro pen delivered takes less than 24 hours.

Step-by-Step: How to Get Mounjaro at Slinic

Here is the exact process at Slinic — from your first click to your first injection.

Do You Qualify for Mounjaro? Slinic Eligibility Criteria

Slinic’s eligibility criteria follow GPhC-compliant prescribing standards for tirzepatide. You are likely eligible if you meet the following criteria. For the complete guide see our full Mounjaro eligibility guide.

You are likely eligible if you have:

• A BMI of 30 or above (obesity), or
• A BMI of 27 or above (overweight) plus at least one of:
  • Type 2 diabetes or pre-diabetes
  • High blood pressure (hypertension)
  • High cholesterol (dyslipidaemia)
  • Obstructive sleep apnoea
  • Cardiovascular disease
  • Non-alcoholic fatty liver disease
• Age 18 or over
• Not currently pregnant or breastfeeding
• No absolute contraindications identified at clinical assessment

You are not currently eligible if you have:

• A personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• A history of acute pancreatitis (requires individual assessment)
• Severe gastrointestinal disease
• Current pregnancy or active breastfeeding

How Long Does It Take to Get Mounjaro in the UK?

At Slinic, the typical timeline from starting your eligibility assessment to having your Mounjaro 2.5mg pen in hand is 24–48 hours. Most assessments submitted during business hours are reviewed and approved the same day. Dispatch is next working day from approval, with cold-chain delivery typically arriving the following day.

What Happens After Your First Mounjaro Order

Getting Mounjaro is the beginning, not the end. Here is what your treatment journey looks like from month 1 through to maintenance — and what Slinic provides at every stage.

Month 1 — Starting at 2.5mg

Your first pen is 2.5mg — the initiation dose. Inject once weekly on the same day each week. Your free starter pack includes needles and a sharps bin. Most patients notice mild appetite reduction by week 2. Your month 1 check-in reviews your tolerance and approves escalation to 5mg. See our Mounjaro week 1 and month 1 guide.

Months 2–5 — Dose escalation

Each month, your Slinic clinician reviews your progress and approves the next dose escalation — from 2.5mg through 5mg, 7.5mg, 10mg, 12.5mg, to a maximum of 15mg. Each dose increase is only approved when your clinician confirms you are ready clinically. See our full dosing schedule guide.

Months 6–18 — Maintenance and maximum results

At your maintenance dose, monthly check-ins continue. Weight loss accumulates over 12–18 months. The 22.5% average weight loss from SURMOUNT-1 was measured at 72 weeks — maximum results take time. See our Mounjaro before and after guide for the full timeline.

Insurance and Self-Pay Options

Private health insurance

Most UK private health insurance policies do not currently cover weight loss medications including Mounjaro — weight management is typically excluded from standard health insurance coverage. Check your policy documents carefully, and contact your insurer directly if you are unsure. A small number of occupational health insurance schemes and executive health plans do include obesity treatment — it is worth checking.

Self-pay at Slinic

Self-pay pricing at Slinic is fixed, transparent, and all-inclusive. Here are the confirmed 2026 prices:

All prices include needles and sharps bin in starter pack. Free monthly clinical check-ins. No subscription. No minimum term. Subject to clinician approval. Prices correct June 2026 — verify at slinic.co.uk.

For a complete cost breakdown including annual totals, see our complete Mounjaro cost guide and our cheapest Mounjaro UK guide.

Switching to Slinic From Another Provider

Switching providers is straightforward. You do not need a letter from your existing provider. You simply complete Slinic’s eligibility assessment (including independent weight verification), provide your current dose and treatment history, and if approved your first Slinic order is dispatched within 24 hours.

Common reasons patients switch to Slinic:

• Current provider operates a subscription model they want to exit
• Dissatisfied with the quality or frequency of clinical support
• Current provider experiencing stock issues at a particular dose
• Wanting a provider that is NHS-contracted and SCOPE-accredited
• Better pricing at Slinic for their current dose

If you are in a minimum-term subscription with your current provider, check your cancellation terms before placing your first Slinic order — in most cases you can cancel from your next billing date.

7 Safety Checks Before You Order Mounjaro From Any Provider

Before ordering from any UK Mounjaro provider — including Slinic — use this checklist.

What to Avoid When Getting Mounjaro in the UK

What Happens During Your Slinic Clinical Assessment

Many patients are curious — and sometimes anxious — about what the online clinical assessment actually involves. Here is a transparent, step-by-step account of exactly what Slinic’s assessment covers and why each element matters clinically.

Section 1: Your personal details and contact information

Name, date of birth, address, and contact details. Used to verify your identity and ensure your medication is dispatched to the right person. Your data is processed in accordance with GDPR and our privacy policy.

Section 2: Current weight, height, and BMI

You will be asked for your current weight and height. You will then be asked to provide independent verification of this — for example, a photograph of your scales showing your current weight. This is a regulatory requirement under GPhC guidance updated February 2025 and cannot be skipped. Any provider that does not ask you to verify your weight is not meeting current regulatory standards.

Section 3: Medical history

You will be asked about relevant medical conditions including:

• Thyroid conditions — particularly any personal or family history of medullary thyroid carcinoma
• Pancreatitis — any history of acute or chronic pancreatitis
• Gastrointestinal conditions — inflammatory bowel disease, gastroparesis, or other significant GI pathology
• Kidney disease — relevant to hydration monitoring on GLP-1 medications
• Liver disease — including fatty liver disease (a condition that Mounjaro may benefit)
• Diabetic retinopathy — requires monitoring if blood sugar improves rapidly
• Cardiovascular disease — Mounjaro may have cardiovascular benefits
• Mental health conditions — standard screening; GLP-1 medications do not cause depression but your baseline is noted

Section 4: Current medications

You will be asked to list all current medications. Key interactions checked include:

• Oral contraceptives — see our contraception guide
• Levothyroxine and thyroid medications — see our thyroid medication guide
• Insulin and other diabetes medications — dose adjustment may be required as blood sugar improves
• Warfarin and anticoagulants — weight loss can affect INR; monitoring guidance will be provided
• Blood pressure medications — may require dose review as blood pressure improves with weight loss

Section 5: Lifestyle and goals

Your clinical assessment concludes with questions about your weight loss goals, previous attempts at weight management, and your readiness to make dietary changes alongside medication. This is not a test — there are no wrong answers. It helps your Slinic clinician personalise the guidance you receive at your monthly check-ins.

The prescriber review

Once you submit your assessment, a registered Slinic prescriber reviews it — not an algorithm, not a junior administrator. If they have questions, they will contact you by phone or message before approving or declining your prescription. In most cases, straightforward assessments are reviewed and approved the same day.

Your First Mounjaro Delivery: What to Expect

When your Mounjaro pen arrives at Slinic, it is dispatched in certified cold-chain packaging — a temperature-controlled box with refrigerant packs that maintains 2–8°C throughout transit. Here is what arrives in your package:

• Your Mounjaro KwikPen (first order: 2.5mg)
• Your free starter pack — pen needles and a licensed sharps bin
• Patient information leaflet
• Instructions for storage and injection technique
• Details of your upcoming monthly check-in

Storage on arrival

Place the pen in your refrigerator (2–8°C) immediately on arrival. Do not freeze. Keep away from the ice compartment and from the back of the fridge where temperatures can drop below 2°C. Once you have used the pen for the first time, it can be kept at room temperature (up to 30°C) for up to 21 days.

Your first injection

Allow the pen to come to room temperature for 30 minutes before your first injection. Choose your injection site — abdomen (at least 2 inches from the navel), outer thigh, or upper arm. Clean with an alcohol wipe. Attach the needle, press firmly against the skin, and press the button. Hold for 10 seconds to ensure full dose delivery. Dispose of the needle immediately in your sharps bin. Full instructions are in your patient information leaflet. If you need additional guidance, contact your Slinic clinician.

Using Private Mounjaro as a Bridge to NHS Access

This is a clinical strategy that is increasingly common — and often not discussed by providers who benefit from keeping patients on private prescriptions indefinitely.

Some patients who are currently paying privately for Mounjaro may become eligible for NHS access as the rollout thresholds widen. The NICE TA1026 rollout is designed to expand over 12 years, gradually lowering the BMI threshold as NHS commissioning capacity grows. Patients who begin private treatment now and lose significant weight may find that their BMI or comorbidity profile changes in ways that affect their future NHS eligibility.

At Slinic, we are transparent about this. When you reach your target weight, or when your circumstances change, we will discuss with you whether continuing private treatment is the right clinical decision or whether NHS access should be explored. Our commercial interest does not override our clinical responsibility to give you honest advice.

Getting Wegovy at Slinic: An Alternative to Consider

Not every patient is best suited to Mounjaro. Wegovy (semaglutide) is an alternative GLP-1 medication with a strong evidence base — 14.9–20.7% average weight loss depending on dose — and a lower price per pen at Slinic. Here is when Wegovy might be the right starting point rather than Mounjaro.

See our full Mounjaro vs Wegovy comparison guide for the complete clinical analysis. Both are available at Slinic with the same clinical oversight and monthly check-in model.

Talking to Your GP About Mounjaro: What to Say and What to Expect

Many patients taking Mounjaro privately want to keep their GP informed — and this is good clinical practice. Here is how to have that conversation productively.

Tell your GP you are taking Mounjaro

Your GP needs to know about all prescription medications you are taking. Mounjaro can affect blood sugar levels, blood pressure, absorption of other oral medications, and — at higher doses — may produce changes in thyroid function tests. Your GP should know so they can take this into account at any clinical reviews.

Ask about NHS eligibility

If you believe you may meet NHS eligibility criteria (BMI 40+ with multiple qualifying conditions), ask your GP specifically about the NHS Mounjaro rollout in your local ICB area. Be prepared to provide documentation of your qualifying health conditions. Be aware that even if you qualify, the process is managed through local prescribing hubs and timelines vary significantly.

Monitoring on Mounjaro

While Slinic provides monthly clinical check-ins, your GP can provide additional monitoring including HbA1c, blood pressure, thyroid function, and annual blood tests. Patients on levothyroxine or blood pressure medication may need dose adjustment as their weight and metabolic profile improve — this requires GP involvement. See our thyroid medication guide for specific guidance.

How to Reorder Mounjaro at Slinic

Reordering at Slinic is straightforward. After your initial prescription and first order, the process for subsequent orders works as follows:

1. Monthly check-in — your Slinic clinician reviews your progress, side effects, and readiness for dose escalation
2. Prescription renewal — your clinician approves and issues your prescription for the next dose or continued maintenance dose
3. Order placement — you place your order online for your approved dose
4. Dispatch and delivery — dispatched within 24 hours; cold-chain tracked delivery £4.99

There is no minimum order commitment. If you need to pause treatment for any reason — surgery, pregnancy, financial constraints, side effects — simply do not reorder. When you are ready to restart, complete a brief reassessment and see our guide to restarting Mounjaro safely after a break.

Coming Soon: Other Weight Loss Medications at Slinic

Beyond Mounjaro, Slinic will be stocking the following treatments as they receive MHRA approval:

• Wegovy pill (oral semaglutide) — MHRA approved 11 June 2026. Commercial launch expected within weeks. Same semaglutide as the injection, in daily tablet form. No needles, no cold storage.
• Orforglipron (Foundayo) — FDA approved April 2026. UK MHRA submission expected mid-2026. Daily oral GLP-1 pill with no fasting protocol. Expected UK private availability late 2026.
• Retatrutide — Phase 3 results (28.3% weight loss) published May 2026. UK submission expected late 2026. Private availability likely 2027–2028.

Register your interest at Slinic now and we will notify you as soon as these treatments become available.

Why Patients Choose Slinic Over Other Mounjaro Providers

There are dozens of ways to get Mounjaro in the UK. Here is an honest comparison of what differentiates Slinic — not marketing claims, but the specific clinical governance standards that separate us from the majority of the market.

The clinical governance markers that matter most — NHS contracting, SCOPE accreditation, and the combination of GPhC registration with LegitScript certification — are held by very few UK providers simultaneously. These are not marketing badges. They are accountability frameworks that require ongoing regulatory compliance and clinical governance review.

Common Questions About Getting Mounjaro We Haven’t Covered Yet

Can I get Mounjaro if I have type 2 diabetes?

Yes — in fact, Mounjaro (tirzepatide) was originally developed for type 2 diabetes before being licensed for weight management. It has a dual benefit for patients with type 2 diabetes: significant weight loss and improved glycaemic control. However, if you are on insulin or sulphonylureas, dose adjustments may be needed as blood sugar improves. Your Slinic clinician will flag this at assessment and liaise with your GP if required. See our eligibility guide.

Can I get Mounjaro if I’ve previously had bariatric surgery?

Patients who have previously undergone bariatric surgery can be eligible for Mounjaro — but require individual clinical assessment. Depending on the type of surgery, the anatomy of the gastrointestinal tract may affect absorption and side effect profile. Your Slinic clinician will review your surgical history carefully at assessment.

Can I get Mounjaro if I’m on antidepressants?

Most antidepressants are compatible with Mounjaro. The main consideration is that Mounjaro slows gastric emptying, which can alter the absorption timing of oral medications. If you take antidepressants at a specific time with food (as many require), discuss timing with your Slinic clinician. There are no known pharmacological interactions between tirzepatide and most common antidepressants at standard doses.

Can I get Mounjaro if I’m trying to conceive?

Mounjaro is not recommended during pregnancy and must be stopped at least 2 months before attempting to conceive. If you are planning pregnancy, discuss this with your Slinic clinician — there is a clear recommended discontinuation timeline and a conversation to have about contraception in the interim. See our contraception guide.

Can I get Mounjaro if I am over 65?

There is no upper age limit for Mounjaro prescribing. Older patients can and do benefit significantly from treatment. Some older patients have more complex medication lists that require careful review, and some may have age-related considerations around muscle mass preservation that require attention during treatment. Your Slinic clinician will take these factors into account at assessment. See our side effects guide for lean muscle preservation guidance.

What if I am rejected by Slinic — can I appeal?

If your Slinic assessment is declined, your clinician will explain the reason and in most cases suggest an appropriate next step — which may include a GP consultation, further clinical investigation, or an alternative treatment. In some cases, a temporary contraindication (such as recent surgery or a medication review) may mean that re-applying in a few months is appropriate. We do not decline assessments arbitrarily — every decision is clinical and is explained.

Frequently Asked Questions

Travelling With Mounjaro: What You Need to Know

Many Slinic patients ask about travelling with Mounjaro — particularly regarding airport security, cold storage, and managing their injection schedule across time zones. Here is the practical clinical guidance.

Flying with Mounjaro

• Mounjaro is allowed in hand luggage — as a prescription medication, it is exempt from the standard 100ml liquid rule. Carry your prescription or a letter from Slinic confirming your medication for security checks — particularly for international flights.
• Keep it cool — unopened pens must be kept at 2–8°C. Use a medication travel cooler or insulated bag with ice packs for journeys over 2–3 hours. Once opened (first use), pens can be kept at room temperature for up to 21 days.
• Sharps at airports — used pen needles in a sharps bin are generally accepted in checked luggage, not hand luggage. Check your specific airline’s policy before travelling with used sharps.

Time zone changes and injection timing

Mounjaro is a once-weekly injection — so time zone changes rarely cause the dosing challenges seen with daily medications. Simply choose a day of the week to inject and maintain that day wherever you are. If travel causes your injection day to shift by a day or two, contact your Slinic clinician for guidance — in most cases a short adjustment is clinically fine.

Ordering while abroad

Slinic delivers to UK addresses only. If you are travelling abroad for an extended period, plan your orders in advance to ensure you have sufficient medication. UK prescriptions cannot legally be dispensed by overseas pharmacies. Contact your Slinic clinician if you need to plan medication supply for an extended trip.

The True Cost of Getting Mounjaro for a Full Year at Slinic

Here is the complete, honest calculation for a full 12-month Mounjaro treatment journey at Slinic — from starting dose to maintenance — including all costs.

Includes pen price, delivery, needles, sharps bin, and free monthly check-ins. No subscription fees, no consultation charges, no hidden add-ons. This is the true all-in cost. Subject to clinician approval at each dose stage.

For a full comparison of Year 1 costs across all providers, and strategies for reducing your total treatment cost, see our complete cheapest Mounjaro UK guide.

What Happens When You Reach Your Target Weight

Getting Mounjaro is the start of a clinical journey, not a one-off transaction. When patients at Slinic approach their target weight, their monthly check-in conversation shifts from escalation to consolidation and long-term planning.

Dose reduction: Some patients who have reached their target weight will discuss with their Slinic clinician whether a lower maintenance dose is sufficient. Moving from 15mg to 12.5mg or 10mg can reduce monthly cost while preserving most of the weight maintenance benefit.

Treatment tapering: For patients who have established strong dietary and lifestyle habits during treatment, gradual tapering can help assess whether those habits are sufficient to maintain weight without full-dose medication — preferable to abrupt discontinuation.

Long-term maintenance: SURMOUNT-4 data shows that most patients who stop Mounjaro abruptly regain significant weight within 12 months. Long-term prescribing at a maintenance dose is increasingly appropriate for obesity — just as anti-hypertensive medication is continued long-term for blood pressure control. Your Slinic clinician will discuss the right approach as you approach your target weight at your monthly check-ins.

If you need to stop for any reason, see our guide to restarting Mounjaro safely. For results at every stage see our Mounjaro before and after UK guide.

Why Being NHS-Contracted Matters When Choosing a Mounjaro Provider

Most patients looking up how to get Mounjaro UK will not know what NHS contracting means or why it matters. Here is why it should be part of your provider evaluation.

An NHS contract requires a pharmacy to meet the NHS’s clinical governance standards — standards that cover staffing qualifications, clinical oversight processes, patient safety procedures, medicines management, and inspection compliance. These standards are not required of privately-only pharmacies. A pharmacy that holds an NHS contract has demonstrated its clinical governance to the NHS’s satisfaction and continues to be held to those standards as a contractual requirement.

Slinic holds an NHS contract covering its Brierfield, Lancashire base. This means the same clinical infrastructure that serves NHS patients — the dispensing procedures, the pharmacist supervision, the patient safety protocols — is also applied to every private Mounjaro patient. It is not a marketing claim. It is a regulatory obligation.

Combined with GPhC registration (No. 1033729), SCOPE accreditation, and LegitScript certification, Slinic’s NHS contract is part of a set of accountability frameworks held simultaneously by very few UK online Mounjaro providers. When you are deciding who to trust with a long-term prescription medication, these frameworks matter.

References

1. NICE TA1026 — Tirzepatide for managing overweight and obesity.
2. GPhC. Guidance for registered pharmacies providing services at a distance. Updated February 2025. pharmacyregulation.org
3. MHRA authorisation of Mounjaro (tirzepatide) for weight management. 2023.
4. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM. 2022;387(3):205-216.
5. MHRA Drug Safety Update. January 2025. Tirzepatide (Mounjaro) — updated guidance.

Related Guides & Treatment Pages